Company profile NGM

Ngm Biopharmaceuticals Inc
ngm bio is a research-driven, clinical stage biopharmaceutical company with a drug discovery platform designed to generate a pipeline of first-in-class biologic drug candidates. our initial r&d focus has been on cardio-metabolic and liver disease, but we believe that our research expertise – comprehensive and grounded in fundamental, interrelated mechanisms of human biology â...€“ is capable of driving the development of new therapies for a wide range of disease areas such as cancer. ngm bio’s comprehensive approach to drug discovery focuses on elucidating the biology of hormones, cell receptors and associated ligands. as we investigate these novel biological mechanisms, we assemble a deep understanding of the relationship between the structure and function of proteins of interest. coupled with our experience in protein and antibody engineering, our approach enables the efficient and targeted generation of potential first-in-class therapeutics with optimized pharmacologic profiles. work Show More
Quarter analysis & expected interest

There is not enough data for NGM Biopharmaceuticals profile to provide analysis

Correlation between past revenue and NGM Biopharmaceuticals profile search interest

There is not enough data for NGM Biopharmaceuticals profile to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM Biopharmaceuticals profile to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM Biopharmaceuticals NGM stock to provide analysis

Correlation between past revenue and NGM Biopharmaceuticals NGM stock search interest

There is not enough data for NGM Biopharmaceuticals NGM stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM Biopharmaceuticals NGM stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM Biopharmaceuticals news to provide analysis

Correlation between past revenue and NGM Biopharmaceuticals news search interest

There is not enough data for NGM Biopharmaceuticals news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM Biopharmaceuticals news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM Biopharmaceutical trials to provide analysis

Correlation between past revenue and NGM Biopharmaceutical trials search interest

There is not enough data for NGM Biopharmaceutical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM Biopharmaceutical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 08:16:29.

After 39 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 52 days it will total up to 112.0.
NGM stock price expected interest is significantly lower compared to previous quarter (-52.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019109
63
-42.2% QoQ
69
9.5% QoQ
126
82.6% QoQ
2020 105
-3.7% YoY -16.7% QoQ
134
112.7% YoY 27.6% QoQ
132
91.3% YoY -1.5% QoQ
70
-44.4% YoY -47.0% QoQ
2021 160
52.4% YoY 128.6% QoQ
154
14.9% YoY -3.8% QoQ
91
-31.1% YoY -40.9% QoQ
21
-70.0% YoY -76.9% QoQ
2022 196
22.5% YoY 833.3% QoQ
163
5.8% YoY -16.8% QoQ
121
33.0% YoY -25.8% QoQ
149
609.5% YoY 23.1% QoQ
2023 115
-41.3% YoY -22.8% QoQ
80
-50.9% YoY -30.4% QoQ
38
-68.6% YoY -52.5% QoQ
236
58.4% YoY 521.1% QoQ
2024 48
-58.3% YoY -79.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NGM stock price search interestLast update: February 09 2024 08:16:28.
Correlation coefficient between keyword and revenue is -0.06
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 08:16:30.

The average 5 years interest of NGM stock price was 9.12 per week.
The last year interest of NGM stock price compared to the last 5 years has changed by -15.24%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 9.49%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM healthcare to provide analysis

Correlation between past revenue and NGM healthcare search interest

There is not enough data for NGM healthcare to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM healthcare to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM liver diseases to provide analysis

Correlation between past revenue and NGM liver diseases search interest

There is not enough data for NGM liver diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM liver diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NGM metabolic diseases to provide analysis

Correlation between past revenue and NGM metabolic diseases search interest

There is not enough data for NGM metabolic diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NGM metabolic diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NGM
Earnings date: 2024-02-27 After close
Company name: Ngm Biopharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-07-09T16:00:00Z

BusinessWire
Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer

2024-04-15T07:57:22-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - NGM BIOPHARMACEUTICALS INC (0001426332) (Filer)

2024-04-09T00:15:15-04:00

SEC
EFFECT Form - Notice of Effectiveness - NGM BIOPHARMACEUTICALS INC (0001426332) (Filer)

2024-04-08T20:05:48-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T20:04:43-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T20:03:30-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T20:02:22-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:18:07-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:16:19-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:14:37-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:14:24-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:14:18-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:14:10-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:12:45-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

2024-04-08T16:12:39-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)